DeepEthogram, a machine learning pipeline for supervised behavior classification from raw pixels

  1. James P Bohnslav
  2. Nivanthika K Wimalasena
  3. Kelsey J Clausing
  4. Yu Y Dai
  5. David A Yarmolinsky
  6. Tomás Cruz
  7. Adam D Kashlan
  8. M Eugenia Chiappe
  9. Lauren L Orefice
  10. Clifford J Woolf
  11. Christopher D Harvey  Is a corresponding author
  1. Harvard Medical School, United States
  2. Boston Children's Hospital, United States
  3. Massachusetts General Hospital, United States
  4. Champalimaud Center for the Unknown, Portugal

Abstract

Videos of animal behavior are used to quantify researcher-defined behaviors-of-interest to study neural function, gene mutations, and pharmacological therapies. Behaviors-of-interest are often scored manually, which is time-consuming, limited to few behaviors, and variable across researchers. We created DeepEthogram: software that uses supervised machine learning to convert raw video pixels into an ethogram, the behaviors-of-interest present in each video frame. DeepEthogram is designed to be general-purpose and applicable across species, behaviors, and video-recording hardware. It uses convolutional neural networks to compute motion, extract features from motion and images, and classify features into behaviors. Behaviors are classified with above 90% accuracy on single frames in videos of mice and flies, matching expert-level human performance. DeepEthogram accurately predicts rare behaviors, requires little training data, and generalizes across subjects. A graphical interface allows beginning-to-end analysis without end-user programming. DeepEthogram's rapid, automatic, and reproducible labeling of researcher-defined behaviors-of-interest may accelerate and enhance supervised behavior analysis.

Data availability

Code is posted publicly on Github and linked in the paper. Video datasets and human annotations are publicly available and linked in the paper.

The following previously published data sets were used

Article and author information

Author details

  1. James P Bohnslav

    Neurobiology, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Nivanthika K Wimalasena

    F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Kelsey J Clausing

    Molecular Biology, Massachusetts General Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Yu Y Dai

    Molecular Biology, Massachusetts General Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. David A Yarmolinsky

    F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Tomás Cruz

    Champalimaud Neuroscience Programme, Champalimaud Center for the Unknown, Lisbon, Portugal
    Competing interests
    The authors declare that no competing interests exist.
  7. Adam D Kashlan

    F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. M Eugenia Chiappe

    Champalimaud Neuroscience Porgramme, Champalimaud Center for the Unknown, Lisbon, Portugal
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1761-0457
  9. Lauren L Orefice

    Molecular Biology, Massachusetts General Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Clifford J Woolf

    Department of Neurobiology, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Christopher D Harvey

    Neurobiology, Harvard Medical School, Boston, United States
    For correspondence
    harvey@hms.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9850-2268

Funding

National Institutes of Health (R01MH107620)

  • Christopher D Harvey

National Science Foundation (GRFP)

  • Nivanthika K Wimalasena

Fundacao para a Ciencia ea Tecnologia (PD/BD/105947/2014)

  • Tomás Cruz

Harvard Medical School Dean's Innovation Award

  • Christopher D Harvey

Harvard Medical School Goldenson Research Award

  • Christopher D Harvey

National Institutes of Health (DP1 MH125776)

  • Christopher D Harvey

National Institutes of Health (R01NS089521)

  • Christopher D Harvey

National Institutes of Health (R01NS108410)

  • Christopher D Harvey

National Institutes of Health (F31NS108450)

  • James P Bohnslav

National Institutes of Health (R35NS105076)

  • Clifford J Woolf

National Institutes of Health (R01AT011447)

  • Clifford J Woolf

National Institutes of Health (R00NS101057)

  • Lauren L Orefice

National Institutes of Health (K99DE028360)

  • David A Yarmolinsky

European Research Council (ERC-Stg-759782)

  • M Eugenia Chiappe

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experimental procedures were approved by the Institutional Animal Care and Use Committees at Boston Children's Hospital (protocol numbers 17-06-3494R and 19-01-3809R) or Massachusetts General Hospital (protocol number 2018N000219) and were performed in compliance with the Guide for the Care and Use of Laboratory Animals.

Copyright

© 2021, Bohnslav et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

Share this article

https://doi.org/10.7554/eLife.63377

Further reading

    1. Neuroscience
    Gergely F Turi, Sasa Teng ... Yueqing Peng
    Research Article

    Synchronous neuronal activity is organized into neuronal oscillations with various frequency and time domains across different brain areas and brain states. For example, hippocampal theta, gamma, and sharp wave oscillations are critical for memory formation and communication between hippocampal subareas and the cortex. In this study, we investigated the neuronal activity of the dentate gyrus (DG) with optical imaging tools during sleep-wake cycles in mice. We found that the activity of major glutamatergic cell populations in the DG is organized into infraslow oscillations (0.01–0.03 Hz) during NREM sleep. Although the DG is considered a sparsely active network during wakefulness, we found that 50% of granule cells and about 25% of mossy cells exhibit increased activity during NREM sleep, compared to that during wakefulness. Further experiments revealed that the infraslow oscillation in the DG was correlated with rhythmic serotonin release during sleep, which oscillates at the same frequency but in an opposite phase. Genetic manipulation of 5-HT receptors revealed that this neuromodulatory regulation is mediated by Htr1a receptors and the knockdown of these receptors leads to memory impairment. Together, our results provide novel mechanistic insights into how the 5-HT system can influence hippocampal activity patterns during sleep.

    1. Neuroscience
    Ulrike Pech, Jasper Janssens ... Patrik Verstreken
    Research Article

    The classical diagnosis of Parkinsonism is based on motor symptoms that are the consequence of nigrostriatal pathway dysfunction and reduced dopaminergic output. However, a decade prior to the emergence of motor issues, patients frequently experience non-motor symptoms, such as a reduced sense of smell (hyposmia). The cellular and molecular bases for these early defects remain enigmatic. To explore this, we developed a new collection of five fruit fly models of familial Parkinsonism and conducted single-cell RNA sequencing on young brains of these models. Interestingly, cholinergic projection neurons are the most vulnerable cells, and genes associated with presynaptic function are the most deregulated. Additional single nucleus sequencing of three specific brain regions of Parkinson’s disease patients confirms these findings. Indeed, the disturbances lead to early synaptic dysfunction, notably affecting cholinergic olfactory projection neurons crucial for olfactory function in flies. Correcting these defects specifically in olfactory cholinergic interneurons in flies or inducing cholinergic signaling in Parkinson mutant human induced dopaminergic neurons in vitro using nicotine, both rescue age-dependent dopaminergic neuron decline. Hence, our research uncovers that one of the earliest indicators of disease in five different models of familial Parkinsonism is synaptic dysfunction in higher-order cholinergic projection neurons and this contributes to the development of hyposmia. Furthermore, the shared pathways of synaptic failure in these cholinergic neurons ultimately contribute to dopaminergic dysfunction later in life.